HIV/AIDS Stem Cell Clinical Trial Results, Benitec (ASX: BLT)
June 17th, 2010
No comments
A key step in bringing this vector to the clinic was to demonstrate that it is both safe and feasible to transfect the vector into human stem cells and for the RNA molecules to persist in the immune cells of the patient. Read more…
Categories: New Trial Results, Stem Cell Technology
